Lysosomotropic Agents as HCV Entry Inhibitors
Author Information
Author(s): Ashfaq Usman, Javed Tariq, Rehman Sidra, Nawaz Zafar, Riazuddin Sheikh
Primary Institution: National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
Can lysosomotropic agents like Chloroquine and NH4Cl inhibit HCV entry by increasing lysosomal pH?
Conclusion
Chloroquine and NH4Cl can significantly reduce HCV infectivity by inhibiting its entry into liver cells.
Supporting Evidence
- Chloroquine and NH4Cl showed more than 50% reduction of virus infectivity at 50 μM and 10 mM concentrations respectively.
- The study demonstrated that increasing lysosomal pH can inhibit HCV entry.
- MTT assays confirmed that the tested concentrations of Chloroquine and NH4Cl were not toxic to liver cells.
Takeaway
This study found that certain drugs can help stop the Hepatitis C virus from getting into liver cells by changing the acidity inside the cells.
Methodology
The study involved testing the effects of Chloroquine and NH4Cl on HCV pseudoparticles in liver cells using MTT assays and luciferase activity measurements.
Limitations
The study primarily focused on in vitro results, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website